相关实验视频

Updated: Jul 16, 2025

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

CD14和CSF1R作为诱导骨关节炎的发育分子标

Meiliang Zheng¹, Zheng Li¹, Yingfa Feng²

¹Department of Orthopedics, The Second Central Hospital of Baoding No. 57 Fanyang Zhong Road, Zhuozhou 072750, Hebei, China.

International journal of clinical and experimental pathology

|September 11, 2023

概括

这项研究揭示了CD14和CSF1R在骨关节炎中高度表达,这表明它们是这种退行性关节疾病的潜在治疗点.

科学领域:

*分子生物学和生物信息学.
* 基因组学和转录组学.
* 骨关节炎研究.

背景情况:

*骨关节炎 (OA) 是一种退行性关节疾病,主要影响关节软骨.
* CD14和CSF1R在关节炎发病过程中的作用尚不清楚.
* 澄清这些角色可以为OA提供新的治疗策略.

研究的目的:

* 调查CD14和CSF1R在骨关节炎中的参与.
* 确定与OA相关的关键基因和途径.
* 探索OA预防和治疗的潜在治疗点.

主要方法:

*从基因表达综合 (GEO) 数据库中分析了骨关节炎数据集 (GSE46750,GSE82107).
*使用R包 limma的差异基因表达分析.
*权重基因共同表达网络分析 (WGCNA),蛋白与蛋白相互作用 (PPI) 网络构建,以及功能丰富分析 (GO,KEGG,Metascape).
*比较毒基因组学数据库 (CTD) 分析和miRNA目标预测.

主要成果:

* 确定了687个差异表达基因 (DEGs),主要富含炎症反应和信号通路.
*通过PPI网络分析发现了20个核心基因,CD14和CSF1R在OA突组织中表达高.
*CTD分析将包括CD14和CSF1R在内的12个核心基因与炎症和其他相关疾病联系起来.

结论:

* CD14和CSF1R在骨关节炎中显著上调.
* 这些基因代表了骨关节炎的有希望的治疗点.
*对CD14和CSF1R的进一步研究可能会导致新的OA治疗方法.

关键词:

CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 CD14 在CSF1R中,CSF1R是最重要的.分子目标是分子目标.骨关节炎是一种关节炎.

更多相关视频

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...